Hyunsun Jo
Founder & Chief Executive Officer Pin Therapeutics
Seminars
Friday 27th February 2026
The Next Generation of Validated Protein Degradation
9:10 am
- Optimizing physical chemical properties for more favourable ADME characteristics of TACs
- Leveraging PROTACs as binders for antibodies, as well as payloads
- Discussing rationally designing candidates that break out of the structural constraints of E3 ligases
